Jessica Hagen
The funds will be used to open new clinics in the U.S.
Drug-discovery platform TandemAI, sleep-care platform BetterNight, health-monitoring system Xandar Kardian and AR/VR platform Healium also announced funding rounds.
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
The mental health platform let go of 15% of its workforce.
DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.
Rock Health’s 2022 Digital Health Consumer Adoption Survey also found non-video telehealth offerings have become more popular.
A Pew Research Center survey of more than 11,000 U.S. adults reveals the majority would feel uncomfortable if their healthcare provider relied on AI for their care.
Users will have access to symptom tracking and educational content, while its enterprise customers can obtain additional on-demand coaching and support.
The latest funding builds off a Series B announced in April.
The teletherapy company reported increased revenue in 2022 thanks to business-to-business growth, but it also posted an $80 million net loss.